A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006490/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is designed to compare the effects of BI 409306 compared to placebo in patients
with cognitive impairment due to Alzheimer's Disease
提供机构：
Vivli
创建时间：
2020-11-20
